Eli Lilly to spend about $8 billion on Loxo Oncology
The drugmaker is adding new cancer treatments to its lineup, paying a 68 percent premium for Loxo shares
The drugmaker is adding new cancer treatments to its lineup, paying a 68 percent premium for Loxo shares